The Gap has a proven model to generate cashflow and profitability and is a steady dividend payer. Read why I am bullish on ...
Ansell’s focus is on its key brands across industrial and healthcare settings. Each market is quite fragmented and Ansell’s market share varies by subsegment, but the firm has consistently held the ...
Buying undervalued companies in the hope that they'll eventually soar requires nerves of steel and infinite patience.
We recently compiled a list of the 12 Best Long-term Stocks to Invest in for High Returns. In this article, we are going to ...
Fortive targets companies with reputable brand names, large installed bases, and strong cash flows. Management has focused particularly on boosting recurring revenue in its portfolio, which has ...
Bernard emphasized strong performances in the QIAstat Diagnostics and QuantiFERON portfolios, with QIAstat achieving 25% CER growth in Q4 and over 660 new system placements in 2024. QuantiFERON grew ...